Brijlaxmi Leasing & Finance is a non-banking financial company that provides loans and invests in equity securities, primarily serving corporate and individual borrowers in India.
The company lacks a durable competitive advantage, as evidenced by low average ROCE (4.6%) and ROE (4.7%) which are below the cost of capital. There is no evidence of low-cost funding or unique underwriting capabilities, and the business relies on waiving interest and purchasing distressed loan portfolios to generate volatile income.
Capital allocation is poor, characterized by heavy lending to related parties and the acquisition of loan portfolios that lack transparency. The company does not pay dividends and has failed to generate consistent returns on its reinvested capital over several years.
The investment collapsed as the company's habit of waiving interest and lending to related parties finally hollowed out the balance sheet. The lack of transparent documentation and missing investment records, previously flagged by auditors, culminated in a massive write-down of assets that were never truly recoverable. As liquidity dried up due to negative cash conversion and high leverage, the firm was unable to service its debt, and the regulatory authorities finally intervened regarding the chronic failure to maintain statutory reserves and tax compliance.
RichFakir rates Brijlaxmi Leasing & Finance Ltd's business quality as poor — 32/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Brijlaxmi Leasing & Finance Ltd is trading about 58% above our estimate of fair value; we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Brijlaxmi Leasing & Finance Ltd is: Not rated. Poor business (score 32), but the valuation is low-confidence, so we are not calling it a bargain.
RichFakir's educational estimate of Brijlaxmi Leasing & Finance Ltd's fair value is about ₹6 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →